NCT06692335 2026-03-27
HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids
Chinese University of Hong Kong
Phase NA Recruiting
Clinical Trials
8 trialsNCT07397715 2026-02-12
MUSA3
Swiss GO Trial Group
Recruiting
NCT06671548 2026-02-02
Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Qilu Pharmaceutical Co., Ltd.
Phase 3 Recruiting
NCT07378098 2026-01-30
to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
JW Pharmaceutical
Phase 3 Recruiting
NCT02163525 2025-09-30
Post Market TRUST - U.S.A. Study
Acessa Health, Inc.
Phase NA Completed
NCT05538689 2025-09-29
SOUL
University of Chicago
Phase 4 Withdrawn
NCT06058728 2025-09-17
Pink Orchid
AbbVie
Withdrawn
NCT03271489 2025-07-22
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
AbbVie
Phase 3 Completed